STOCK TITAN

Nordson Corporation Reports Second Quarter Fiscal 2024 Results and Updates Annual Guidance

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nordson (Nasdaq: NDSN) reported its fiscal Q2 2024 results with sales of $651 million, matching last year's figure. Net income stood at $118 million, equating to $2.05 per diluted share, a slight decrease from the previous year's $128 million and $2.21 per share. Adjusted earnings were $2.34 per share, down from $2.45. EBITDA remained flat at $203 million, representing 31% of sales.

Segment-wise, Industrial Precision Solutions saw a 9% sales increase to $367 million, while Medical and Fluid Solutions experienced a 2% rise to $169 million. Advanced Technology Solutions, however, faced a 22% decline in sales to $115 million.

Nordson updated its full-year fiscal 2024 guidance to forecast flat to 2% revenue growth, with adjusted EPS expected to range between $9.35 and $9.75. Q3 sales are projected between $645 and $670 million, with adjusted EPS of $2.25 to $2.40.

Positive
  • Q2 2024 sales of $651 million, comparable to prior year.
  • Industrial Precision Solutions sales increased 9% to $367 million.
  • Medical and Fluid Solutions sales rose 2% to $169 million.
  • EBITDA remained strong at $203 million, 31% of sales.
  • Updated full-year revenue guidance to flat to 2% growth over 2023.
  • Q3 2024 sales forecasted between $645 and $670 million.
  • Q3 2024 adjusted EPS expected between $2.25 and $2.40.
Negative
  • Net income decreased to $118 million from $128 million.
  • Earnings per diluted share down to $2.05 from $2.21.
  • Adjusted earnings per share fell to $2.34 from $2.45.
  • Organic sales declined by 4%, driven by pressure in electronics product lines.
  • Advanced Technology Solutions sales dropped 22% to $115 million.
  • Increased interest expense from prior year acquisitions affecting finances.
  • Higher selling and administrative expenses due to the ARAG acquisition.

Nordson Corporation's second quarter fiscal 2024 results reveal a mixed yet stable financial performance. The sales figure of $651 million remains consistent with the same period last year. However, the organic sales decrease of 4% due to ongoing pressure in electronics product lines is a point of concern, counterbalanced by growth in industrial coatings and fluid solutions product lines.

Net income of $118 million, translating to $2.05 per diluted share, marks a decline from the prior year's $128 million ($2.21 per diluted share). This decline reflects increased interest expense from previous acquisitions. The adjusted earnings per share of $2.34, though slightly lower than last year's $2.45, still showcases resilience in profitability management amid higher administrative costs and acquisition-related expenses.

The company's EBITDA of $203 million, or 31% of sales, is in line with the previous year, indicating operational stability. However, investors should note the adjusted guidance for full-year revenue growth, now expected to be flat to 2%, suggesting cautious optimism amid current market pressures. The updated adjusted earnings per share guidance of $9.35 to $9.75 aligns with a prudent outlook given the mixed segment performances and ongoing market uncertainties.

Overall, while there are underlying challenges, the company's diversified portfolio and strong operational focus provide a balanced view of stability and cautious growth potential.

The breakdown of Nordson's second quarter performance across its segments provides valuable insights into the broader market dynamics. The Industrial Precision Solutions (IPS) segment saw a 9% sales increase, driven by both acquisition impact and a 2% organic growth. This indicates strong demand in industrial coatings systems and packaging, reflecting healthy industrial activity.

Conversely, the Advanced Technology Solutions (ATS) segment experienced a significant 22% sales decrease, underscoring the ongoing weakness in electronics-related markets. The decremental margin of 22% and reduced EBITDA margin to 21% highlight the pressure this segment is under.

The Medical and Fluid Solutions (MFS) segment's modest 2% sales growth, with stable EBITDA at 37% of sales, suggests steady but not exceptional performance. The segment's resilience in fluid and interventional solutions is a positive marker amid broader market pressures.

Looking ahead, the company's substantial backlog of $700 million offers a cushion against current market volatilities. The updated guidance indicates a tempered growth outlook, with the electronics cycle and European agriculture sector posing near-term challenges. However, the diversified nature of Nordson's operations and strong recurring revenue streams provide a solid foundation for long-term growth.

Nordson's Advanced Technology Solutions (ATS) segment's performance is critical for understanding the impact of the ongoing electronics cycle. The 22% decrease in sales within this segment is significant, indicating substantial pressure and a slowdown in electronics market demand. This is particularly pertinent as electronics represent a rapidly evolving sector with high sensitivity to market cycles.

The decremental margin of 22% and reduced EBITDA margin from 22% to 21% reflect not only decreased sales but also potentially higher fixed costs and lower utilization rates. This underscores the importance of monitoring market indicators and potential recovery signs in the electronics sector for future performance.

It's notable that Nordson expects these impacts to be temporary, aligning with broader market expectations of a rebound in electronics demand. The strategic focus on innovation and diversification within the segment could position the company well to capitalize on future growth opportunities once the market cycle improves.

Second Quarter:

  • Sales were $651 million
  • Net income was $118 million
  • Earnings per diluted share were $2.05
  • Adjusted earnings per diluted share were $2.34
  • EBITDA was $203 million, 31% of sales

Guidance:

  • Updating full-year fiscal 2024 revenue guidance to the range of flat to 2% growth over record fiscal 2023 and adjusted earnings per diluted share to the range of $9.35 to $9.75 per share

WESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal second quarter ended April 30, 2024. Sales were $651 million, comparable to the prior year’s second quarter sales of $650 million. The second quarter 2024 sales included a favorable acquisition impact of 5%, partially offset by an organic sales decrease of 4%. The organic sales decrease was driven by ongoing pressure in electronics product lines, partially offset by growth in industrial coatings systems and fluid solutions product lines.

Net income was $118 million, or $2.05 of earnings per diluted share, compared to prior year’s second quarter net income of $128 million, or $2.21 of earnings per diluted share. Adjusted net income was $135 million, a decrease from the prior year adjusted net income of $141 million. Second quarter 2024 adjusted earnings per diluted share were $2.34, a 4% decrease from the prior year adjusted earnings per diluted share of $2.45. The decrease was driven primarily by increased interest expense from prior year acquisitions.

EBITDA in the second quarter was $203 million, or 31% of sales, compared to prior year EBITDA of $203 million, or 31% of sales. EBITDA was flat as improved gross margins were offset by higher selling and administrative expenses primarily related to the first-year effect of the ARAG acquisition.

Commenting on the Company’s fiscal 2024 second quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “Once again, the teams delivered a solid operating performance, delivering strong gross margins and 31% EBITDA margin. Our sales were in line with management expectations with the IPS and MFS segments delivering organic growth. While we see positive early indicators, our Advanced Technology Solutions segment remains impacted by the electronics cycle. I am pleased with our ability to manage profitability during this period.”

Second Quarter Segment Results

Industrial Precision Solutions sales of $367 million increased 9% from the prior year, inclusive of an acquisition impact and an organic sales increase of 2%. The organic sales increase was driven primarily by industrial coatings systems and packaging product lines. Operating profit was $118 million, an increase of $6 million from the prior year. EBITDA in the quarter was $132 million, or 36% of sales, an 11% increase from the prior year second quarter EBITDA of $119 million, or 35% of sales. The year-over-year increase was driven by the ARAG acquisition and higher organic sales and gross profit.

Medical and Fluid Solutions sales of $169 million increased 2% compared to the prior year second quarter. The increase was driven by growth in the fluid and interventional solutions product lines. Operating profit was $49 million, an increase of $1 million from the prior year. EBITDA in the quarter was $63 million, or 37% of sales, flat versus the prior year second quarter EBITDA of $63 million, or 38% of sales.

Advanced Technology Solutions sales of $115 million decreased 22% compared to the prior year second quarter. The organic sales decrease was driven by weakness across the segment. Operating profit was $19 million, a decrease of $7 million from the prior year with a decremental margin of 22%. EBITDA in the quarter was $24 million, or 21% of sales, a decrease from the prior year second quarter EBITDA of $32 million, or 22% of sales.

Outlook

The Company is entering the third quarter of fiscal 2024 with approximately $700 million in backlog, which continues to normalize and remain concentrated in systems businesses. Based on current visibility and order entry trends, the Company is updating its full-year revenue guidance range to flat to 2% growth over record fiscal 2023 and adjusted earnings per diluted share to the range of $9.35 to $9.75 per diluted share. Third quarter fiscal 2024 sales are forecasted in the range of $645 to $670 million with adjusted earnings in the range of $2.25 to $2.40 per diluted share.

Reflecting on the outlook, Nagarajan continued, “As we move into the second half of fiscal 2024, the positive indicators in the electronics end markets have not yet converted into orders needed to meet our previously issued guidance. We are also experiencing increased pressure from the agriculture cycle in Europe, which is causing OEMs to slow investments in spray implement purchases. In each of these cases, we believe the impact is temporary and we remain confident in the long-term growth drivers of these respective end markets. Our core strengths remain: a diversified portfolio, close to the customer business model, high-level of recurring revenue, NBS Next growth framework, and commitment to innovation. All of this positions Nordson well to deliver our long-term Ascend Strategy goals.”

Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Tuesday, May 21, 2024 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.

The Company’s definition of adjusted earnings excludes acquisition related amortization for both current and historical periods. It is not possible for the Company to identify the amount or significance of future adjustments associated with acquisition and integration costs, restructuring costs, acquisition-related amortization, certain non-operating or income tax items, or other non-routine costs that the Company adjusts in the presentation of adjusted earnings guidance. These items are dependent on future events that are not reasonably estimable at this time. Accordingly, the Company is unable to reconcile without unreasonable effort the forecasted range of adjusted earnings guidance to a comparable GAAP range.

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, linkedin/Nordson, or www.facebook.com/nordson.

 

NORDSON CORPORATION

CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(Dollars in thousands except for per-share amounts)

 

 

Three Months Ended

 

Six Months Ended

 

April 30, 2024

 

April 30, 2023

 

April 30, 2024

 

April 30, 2023

Sales

$

650,642

 

 

$

650,165

 

 

$

1,283,835

 

 

$

1,260,642

 

Cost of sales

 

284,765

 

 

 

298,040

 

 

 

569,531

 

 

 

579,650

 

Gross profit

 

365,877

 

 

 

352,125

 

 

 

714,304

 

 

 

680,992

 

Gross margin %

 

56.2

%

 

 

54.2

%

 

 

55.6

%

 

 

54.0

%

 

 

 

 

 

 

 

 

Selling & administrative expenses

 

197,261

 

 

 

179,618

 

 

 

386,253

 

 

 

364,266

 

Operating profit

 

168,616

 

 

 

172,507

 

 

 

328,051

 

 

 

316,726

 

 

 

 

 

 

 

 

 

Interest expense - net

 

(18,555

)

 

 

(9,475

)

 

 

(38,953

)

 

 

(19,418

)

Other expense - net

 

(785

)

 

 

(1,405

)

 

 

(1,123

)

 

 

(4,601

)

Income before income taxes

 

149,276

 

 

 

161,627

 

 

 

287,975

 

 

 

292,707

 

 

 

 

 

 

 

 

 

Income taxes

 

31,059

 

 

 

34,064

 

 

 

60,186

 

 

 

60,883

 

 

 

 

 

 

 

 

 

Net income

$

118,217

 

 

$

127,563

 

 

$

227,789

 

 

$

231,824

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

57,222

 

 

 

57,184

 

 

 

57,142

 

 

 

57,177

 

Diluted

 

57,681

 

 

 

57,680

 

 

 

57,617

 

 

 

57,721

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

Basic earnings

$

2.07

 

 

$

2.23

 

 

$

3.99

 

 

$

4.05

 

Diluted earnings

$

2.05

 

 

$

2.21

 

 

$

3.95

 

 

$

4.02

 

 

NORDSON CORPORATION

CONSOLIDATED BALANCE SHEETS (Unaudited)

(Dollars in thousands)

 

 

April 30, 2024

 

October 31, 2023

Cash and cash equivalents

$

125,446

 

$

115,679

Receivables - net

 

530,283

 

 

 

590,886

 

Inventories - net

 

443,578

 

 

 

454,775

 

Other current assets

 

86,283

 

 

 

67,970

 

Total current assets

 

1,185,590

 

 

 

1,229,310

 

 

 

 

 

Property, plant and equipment - net

 

395,595

 

 

 

392,846

 

Goodwill

 

2,782,909

 

 

 

2,784,201

 

Other assets

 

807,777

 

 

 

845,413

 

 

$

5,171,871

 

 

$

5,251,770

 

 

 

 

 

Notes payable and debt due within one year

$

119,328

 

 

$

115,662

 

Accounts payable and accrued liabilities

 

416,683

 

 

 

466,427

 

Total current liabilities

 

536,011

 

 

 

582,089

 

 

 

 

 

Long-term debt

 

1,414,363

 

 

 

1,621,394

 

Other liabilities

 

433,226

 

 

 

450,227

 

Total shareholders' equity

 

2,788,271

 

 

 

2,598,060

 

 

$

5,171,871

 

 

$

5,251,770

 

 

 

 

 

 

NORDSON CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

(Dollars in thousands)

 

 

Six Months Ended

 

April 30, 2024

 

April 30, 2023

Cash flows from operating activities:

 

 

 

Net income

$

227,789

 

 

$

231,824

 

Depreciation and amortization

 

66,264

 

 

 

53,535

 

Other non-cash items

 

10,281

 

 

 

11,458

 

Changes in working capital

 

(3,435

)

 

 

(45,857

)

Other

 

(5,935

)

 

 

36,945

 

Net cash provided by operating activities

 

294,964

 

 

 

287,905

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Additions to property, plant and equipment

 

(21,907

)

 

 

(15,349

)

Acquisition of businesses, net of cash acquired

 

 

 

 

(377,843

)

Other - net

 

6,730

 

 

 

39

 

Net cash used in investing activities

 

(15,177

)

 

 

(393,153

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Issuance (repayment) of long-term debt

 

(204,372

)

 

 

184,617

 

Repayment of finance lease obligations

 

(2,881

)

 

 

(2,775

)

Dividends paid

 

(77,796

)

 

 

(74,463

)

Issuance of common shares

 

27,219

 

 

 

11,808

 

Purchase of treasury shares

 

(7,927

)

 

 

(54,365

)

Net cash provided (used) in financing activities

 

(265,757

)

 

 

64,822

 

 

 

 

 

Effect of exchange rate change on cash:

 

(4,263

)

 

 

6,042

 

Net change in cash and cash equivalents

 

9,767

 

 

 

(34,384

)

 

 

 

 

Cash and cash equivalents:

 

 

 

Beginning of period

 

115,679

 

 

 

163,457

 

End of period

$

125,446

 

 

$

129,073

 

 

 

 

 

 

NORDSON CORPORATION

SALES BY GEOGRAPHIC SEGMENT (Unaudited)

(Dollars in thousands)

 

 

Three Months Ended

 

Sales Variance

 

April 30, 2024

 

April 30, 2023

 

Organic

 

Acquisitions

 

Currency

 

Total

SALES BY SEGMENT

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

366,991

 

$

335,807

 

1.5

%

 

8.6

%

 

(0.8

)%

 

9.3

%

Medical and Fluid Solutions

 

168,966

 

 

 

166,526

 

 

1.8

%

 

%

 

(0.3

)%

 

1.5

%

Advanced Technology Solutions

 

114,685

 

 

 

147,832

 

 

(21.6

)%

 

%

 

(0.8

)%

 

(22.4

)%

Total sales

$

650,642

 

 

$

650,165

 

 

(3.7

)%

 

4.5

%

 

(0.7

)%

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

SALES BY GEOGRAPHIC REGION

 

 

 

 

 

 

 

 

 

 

 

Americas

$

294,428

 

 

$

278,731

 

 

2.9

%

 

2.3

%

 

0.4

%

 

5.6

%

Europe

 

182,070

 

 

 

167,904

 

 

(4.4

)%

 

12.5

%

 

0.3

%

 

8.4

%

Asia Pacific

 

174,144

 

 

 

203,530

 

 

(12.3

)%

 

0.7

%

 

(2.8

)%

 

(14.4

)%

Total sales

$

650,642

 

 

$

650,165

 

 

(3.7

)%

 

4.5

%

 

(0.7

)%

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

Sales Variance

 

April 30, 2024

 

April 30, 2023

 

Organic

 

Acquisitions

 

Currency

 

Total

SALES BY SEGMENT

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

721,538

 

 

$

647,353

 

 

1.9

%

 

9.6

%

 

%

 

11.5

%

Medical and Fluid Solutions

 

328,492

 

 

 

320,813

 

 

2.4

%

 

%

 

%

 

2.4

%

Advanced Technology Solutions

 

233,805

 

 

 

292,476

 

 

(19.6

)%

 

%

 

(0.5

)%

 

(20.1

)%

Total sales

$

1,283,835

 

 

$

1,260,642

 

 

(2.9

)%

 

4.9

%

 

(0.2

)%

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

 

SALES BY GEOGRAPHIC REGION

 

 

 

 

 

 

 

 

 

 

 

Americas

$

568,440

 

 

$

543,610

 

 

1.3

%

 

2.8

%

 

0.5

%

 

4.6

%

Europe

 

361,380

 

 

 

330,843

 

 

(5.7

)%

 

13.4

%

 

1.5

%

 

9.2

%

Asia Pacific

 

354,015

 

 

 

386,189

 

 

(6.7

)%

 

0.7

%

 

(2.3

)%

 

(8.3

)%

Total sales

$

1,283,835

 

 

$

1,260,642

 

 

(2.9

)%

 

4.9

%

 

(0.2

)%

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)

(Dollars in thousands)

 

 

Three Months Ended

 

Six Months Ended

 

April 30, 2024

 

April 30, 2023

 

April 30, 2024

 

April 30, 2023

Net income

$

118,217

 

$

127,563

 

$

227,789

 

$

231,824

Income taxes

 

31,059

 

 

 

34,064

 

 

 

60,186

 

 

 

60,883

 

Interest expense - net

 

18,555

 

 

 

9,475

 

 

 

38,953

 

 

 

19,418

 

Other expense - net

 

785

 

 

 

1,405

 

 

 

1,123

 

 

 

4,601

 

Depreciation and amortization

 

32,720

 

 

 

27,100

 

 

 

66,264

 

 

 

53,535

 

Inventory step-up amortization (1)

 

 

 

 

 

 

 

2,944

 

 

 

4,306

 

Severance and other

 

2,078

 

 

 

3,439

 

 

 

2,078

 

 

 

3,439

 

Acquisition-related costs (1)

 

 

 

 

 

 

 

597

 

 

 

5,989

 

EBITDA (non-GAAP) (2)

$

203,414

 

 

$

203,046

 

 

$

399,934

 

 

$

383,995

 

(1)

Represents fees, severance and non-cash inventory charges associated with acquisitions.

(2)

EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

 

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited)

(Dollars in thousands)

 

 

Three Months Ended

 

Six Months Ended

 

April 30, 2024

 

April 30, 2023

 

April 30, 2024

 

April 30, 2023

SALES BY SEGMENT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

366,991

 

 

 

 

$

335,807

 

 

 

 

$

721,538

 

 

 

 

$

647,353

 

 

 

Medical and Fluid Solutions

 

168,966

 

 

 

 

 

166,526

 

 

 

 

 

328,492

 

 

 

 

 

320,813

 

 

 

Advanced Technology Solutions

 

114,685

 

 

 

 

 

147,832

 

 

 

 

 

233,805

 

 

 

 

 

292,476

 

 

 

Total sales

$

650,642

 

 

 

 

$

650,165

 

 

 

 

$

1,283,835

 

 

 

 

$

1,260,642

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING PROFIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

117,831

 

 

 

 

$

111,773

 

 

 

 

$

226,195

 

 

 

 

$

214,093

 

 

 

Medical and Fluid Solutions

 

48,993

 

 

 

 

 

47,922

 

 

 

 

 

95,093

 

 

 

 

 

87,307

 

 

 

Advanced Technology Solutions

 

18,784

 

 

 

 

 

26,090

 

 

 

 

 

37,822

 

 

 

 

 

43,053

 

 

 

Corporate

 

(16,992

)

 

 

 

 

(13,278

)

 

 

 

 

(31,059

)

 

 

 

 

(27,727

)

 

 

Total operating profit

$

168,616

 

 

 

 

$

172,507

 

 

 

 

$

328,051

 

 

 

 

$

316,726

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING PROFIT ADJUSTMENTS (1)

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

 

 

 

 

$

 

 

 

 

$

3,541

 

 

 

 

$

 

 

 

Medical and Fluid Solutions

 

 

 

 

 

 

1,479

 

 

 

 

 

 

 

 

 

 

1,479

 

 

 

Advanced Technology Solutions

 

2,078

 

 

 

 

 

1,960

 

 

 

 

 

2,078

 

 

 

 

 

12,255

 

 

 

Total adjustments

$

2,078

 

 

 

 

$

3,439

 

 

 

 

$

5,619

 

 

 

 

$

13,734

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DEPRECIATION & AMORTIZATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

13,920

 

 

 

 

$

7,285

 

 

 

 

$

28,300

 

 

 

 

$

14,130

 

 

 

Medical and Fluid Solutions

 

13,564

 

 

 

 

 

13,683

 

 

 

 

 

27,269

 

 

 

 

 

27,308

 

 

 

Advanced Technology Solutions

 

3,284

 

 

 

 

 

4,010

 

 

 

 

 

6,725

 

 

 

 

 

7,822

 

 

 

Corporate

 

1,952

 

 

 

 

 

2,122

 

 

 

 

 

3,970

 

 

 

 

 

4,275

 

 

 

Total depreciation & amortization

$

32,720

 

 

 

 

$

27,100

 

 

 

 

$

66,264

 

 

 

 

$

53,535

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA (NON-GAAP) (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Precision Solutions

$

131,751

 

 

36

%

 

$

119,058

 

 

35

%

 

$

258,036

 

 

36

%

 

$

228,223

 

 

35

%

Medical and Fluid Solutions

 

62,557

 

 

37

%

 

 

63,084

 

 

38

%

 

 

122,362

 

 

37

%

 

 

116,094

 

 

36

%

Advanced Technology Solutions

 

24,146

 

 

21

%

 

 

32,060

 

 

22

%

 

 

46,625

 

 

20

%

 

 

63,130

 

 

22

%

Corporate

 

(15,040

)

 

 

 

 

(11,156

)

 

 

 

 

(27,089

)

 

 

 

 

(23,452

)

 

 

Total EBITDA

$

203,414

 

 

31

%

 

$

203,046

 

 

31

%

 

$

399,934

 

 

31

%

 

$

383,995

 

 

30

%

(1)

Represents severance as well as fees and non-cash inventory charges associated with acquisitions.

(2)

EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

 

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited)

(Dollars in thousands)

 

 

Three Months Ended

 

Six Months Ended

 

April 30, 2024

 

April 30, 2023

 

April 30, 2024

 

April 30, 2023

GAAP AS REPORTED

 

 

 

 

 

 

 

Operating profit

$

168,616

 

 

$

172,507

 

 

$

328,051

 

 

$

316,726

 

Other / interest expense - net

 

(19,340

)

 

 

(10,880

)

 

 

(40,076

)

 

 

(24,019

)

Net income

 

118,217

 

 

 

127,563

 

 

 

227,789

 

 

 

231,824

 

Diluted earnings per share

$

2.05

 

 

$

2.21

 

 

$

3.95

 

 

$

4.02

 

 

 

 

 

 

 

 

 

Shares outstanding - diluted

 

57,681

 

 

 

57,680

 

 

 

57,617

 

 

 

57,721

 

 

 

 

 

 

 

 

 

OPERATING PROFIT ADJUSTMENTS

 

 

 

 

 

 

 

Inventory step-up amortization

$

 

 

$

 

 

$

2,944

 

 

$

4,306

 

Acquisition-related costs

 

 

 

 

 

 

 

597

 

 

 

5,989

 

Severance and other

 

2,078

 

 

 

3,439

 

 

 

2,078

 

 

 

3,439

 

 

 

 

 

 

 

 

 

ACQUISITION AMORTIZATION OF INTANGIBLES

$

18,823

 

 

$

14,044

 

 

 

38,210

 

 

 

27,917

 

 

 

 

 

 

 

 

 

Total adjustments

$

20,901

 

 

$

17,483

 

 

$

43,829

 

 

$

41,651

 

 

 

 

 

 

 

 

 

Adjustments net of tax

$

16,556

 

 

$

13,798

 

 

$

34,669

 

 

$

32,988

 

EPS effect of adjustments and other discrete tax items

$

0.29

 

 

$

0.24

 

 

$

0.60

 

 

$

0.57

 

 

 

 

 

 

 

 

 

NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

 

 

 

 

 

 

 

Adjusted Net income (1)

$

134,773

 

 

$

141,361

 

 

$

262,458

 

 

$

264,812

 

Adjusted Diluted earnings per share (2)

$

2.34

 

 

$

2.45

 

 

$

4.55

 

 

$

4.59

 

(1)

Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.

(2)

Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

Lara Mahoney

Vice President, Investor Relations & Corporate Communications

440.204.9985

Lara.Mahoney@nordson.com

Source: Nordson Corporation

FAQ

What were Nordson's Q2 2024 sales?

Nordson's Q2 2024 sales were $651 million, comparable to the prior year's $650 million.

What was Nordson's Q2 2024 net income?

Nordson's Q2 2024 net income was $118 million, down from $128 million in the prior year.

How did Nordson's Q2 2024 earnings per share compare to last year?

Nordson's Q2 2024 earnings per diluted share were $2.05, compared to $2.21 in the previous year.

What is Nordson's updated full-year fiscal 2024 revenue guidance?

Nordson's updated full-year fiscal 2024 revenue guidance is flat to 2% growth over record fiscal 2023.

What was Nordson's Q2 2024 EBITDA?

Nordson's Q2 2024 EBITDA was $203 million, consistent with the prior year.

What is Nordson's Q3 2024 sales forecast?

Nordson's Q3 2024 sales are forecasted to be in the range of $645 to $670 million.

What was the impact of the ARAG acquisition on Nordson's Q2 2024 results?

The ARAG acquisition contributed to higher selling and administrative expenses, impacting Nordson's Q2 2024 results.

How did Advanced Technology Solutions perform in Q2 2024 for Nordson?

Advanced Technology Solutions sales decreased by 22% to $115 million in Q2 2024.

What are Nordson's projected Q3 2024 adjusted EPS?

Nordson's projected Q3 2024 adjusted EPS are expected to be between $2.25 and $2.40.

What led to the decline in Nordson's Q2 2024 organic sales?

The decline in Nordson's Q2 2024 organic sales was driven by ongoing pressure in electronics product lines.

Nordson Corporation

NASDAQ:NDSN

NDSN Rankings

NDSN Latest News

NDSN Stock Data

13.10B
51.92M
10.48%
74.92%
1.42%
Heating Equipment (except Warm Air Furnaces) Manufacturing
Manufacturing
Link
United States of America
WESTLAKE